First-Line Panitumumab + Capecitabine in Older Patients With Wild-Type RAS Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Geriatric Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-Line Panitumumab Plus Capecitabine for the Treatment of Older Patients With Wild-Type RAS Metastatic Colorectal Cancer. The Phase II, PANEL study
J Geriatr Oncol 2020 Jun 21;[EPub Ahead of Print], JC Méndez Méndez, M Salgado Fernández, J de la Cámara Gómez, ML Pellón Augusto, M Covela Rua, G Quintero Aldana, A Fernández Montes, M Reboredo López, M Valladares Ayerbes, M Jorge Fernández, P González Villarroel, C Romero Reinoso, M Ramos VázquezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.